Scientists Finally Crack an "Undruggable" Pancreatic Cancer Target
Pancreatic cancer has long been one of the most lethal cancers, with few effective treatment options available to patients. However, a new drug called daraxonrasib is offering renewed hope after successfully targeting the KRAS mutation that fuels the majority of pancreatic tumors—an approach many scientists once considered impossible.
In